Sandra Sofia Pinhanços

Sandra Sofia Pinhanços

Auto-generated profile, based on publicly available information

Sandra Sofia Pinhanços

Princess Màxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2012 in Leukemia
Verified
Journal Article
Closed access
JSJ A P Spijkers-Hagelstein
J A P Spijkers-Hagelstein
SPS Mimoso Pinhanços
S Mimoso Pinhanços
PSP Schneider
P Schneider
RPR Pieters
R Pieters
RSR W Stam
R W Stam

10 July 2017 in Leukemia
Verified
Journal Article
Closed access
PCP Garrido Castro
P Garrido Castro
ERE H J van Roon
E H J van Roon
SPS S Pinhanços
S S Pinhanços
LTL Trentin
L Trentin
PSP Schneider
P Schneider
RSR W Stam
R W Stam

31 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
MKMark Kerstjens
Mark Kerstjens
EDEmma M.C. Driessen
Emma M.C. Driessen
MWMerel Willekes
Merel Willekes
SPSandra S. Pinhanços
Sandra S. Pinhanços
PSPauline Schneider
Pauline Schneider
RSRonald W. Stam
Ronald W. Stam
MEK inhibition is a promising therapeutic strategy for MLL -rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations

1 March 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AHArie J. Hoogendijk
Arie J. Hoogendijk
SPSandra S. Pinhanços
Sandra S. Pinhanços
TPTom van der Poll
Tom van der Poll
CWCatharina W. Wieland
Catharina W. Wieland
Adenosine monophosphate-activated protein (AMP)-activated kinase (AMPK) is a highly conserved kinase that plays a key role in energy homeostasis. Activation of AMPK was shown to reduce inflammation in response to lipolysaccharide in vitro and in vivo. 5-Aminoimidazole-4-carbox-amide-1-β-d-ribofuranoside (AICAR) is intracellularly converted to the AMP analog ZMP, which activates AMPK. Lipoteichoic acid (LTA) is a major component of the cell wall of Gram-positive bacteria that can trigger inflammatory responses. In contrast to lipopolysaccharide, little is known on the effects of AMPK activation in LTA-triggered innate immune responses. Here, we studied the potency of AMPK activation to reduce LTA-induced inflammation in vitro and in lungs in vivo. Activation of AMPK in vitro reduced cytokine production in the alveolar macrophage cell line MH-S. In vivo, AMPK activation reduced LTA-induced neutrophil influx, as well as protein leak and cytokine/chemokine levels in the bronchoalveolar space. In conclusion, AMPK activation inhibits LTA-induced lung inflammation in mice.

1 February 2018 in Haematologica
Verified
Journal Article
Closed access
PDF file
MKMark Kerstjens
Mark Kerstjens
SPSandra S. Pinhancos
Sandra S. Pinhancos
PCPatricia Garrido Castro
Patricia Garrido Castro
PSPauline Schneider
Pauline Schneider
PWPriscilla Wander
Priscilla Wander
RSRonald W. Stam
Ronald W. Stam

20 August 2013 in Leukemia
Verified
Journal Article
Closed access
JSJ A P Spijkers-Hagelstein
J A P Spijkers-Hagelstein
SPS S Pinhanços
S S Pinhanços
PSP Schneider
P Schneider
RPR Pieters
R Pieters
RSR W Stam
R W Stam